Through genetic validation, we show that while loss of Smarca5 alone in GCNPs, the proposed cell origin of SHH-MB7does not induce tumor formation in mice, it rather affects their proliferative capacity during early postnatal development and results in increased apoptotic activity, thus leading to a severe cerebellar phenotype in mice. This evidence concerns the gene SMARCA5 and neoplasm.